56
Last year, it seemed that the battle to preserve access in the US to mifepristone as an option for abortion had been won, but as the Trump administration launches a review of the drug, it seems the war isn’t over.
A letter from HHS Secretary Robert F Kennedy Jr. and FDA Commissioner Martin Makary, in which they confirmed that the FDA is conducting a ‘review’ of mifepristone’s safety, has raised the spectre of controls being placed on the drug without evidence of harm.
It comes on the back of a request from 22 Republican attorneys general for the FDA to look into the safety of the drug.
The…